Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-10-22FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for amlodipine besylate.
-
FDA approval · 2010-10-04FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for PROCARDIA XL (nifedipine) from Pfizer Laboratories Div Pfizer Inc, indicating changes under …
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Neurostimulation to Treat Refractory Angina Pectoris Pain [Phase 3]
A Phase 3 trial evaluating neurostimulation to treat refractory angina pectoris was terminated.
-
FDA approval · 2010-08-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for verapamil hydrochloride from Mylan Pharmaceuticals Inc., granting/confirming approval for a …
-
FDA approval · 2010-07-12FDA Approved: NITROSTAT — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Nitrostat (nitroglycerin) submitted by Viatris Specialty LLC, resulting in an updated labeli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-07-06FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for atenolol submitted by Rising Pharma Holdings, Inc.
-
FDA approval · 2010-06-30FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for amlodipine besylate by Aurobindo Pharma Limited as a generic product.
-
FDA approval · 2010-05-11FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for amlodipine besylate from Zydus Pharmaceuticals USA Inc., granting approval for the generic produ…
-
FDA approval · 2010-04-30FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application to allow amlodipine besylate 2.5 mg as an additional dosage strength for Oxford Pharmaceuticals' pro…
-
FDA approval · 2010-04-07FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Original Application (Oxford Pharmaceuticals, LLC)
FDA approved the Original Application for amlodipine besylate 2.5 mg by Oxford Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: The Effects of Diesel Exhaust Inhalation On Exercise Capacity In Patients With Stable Angina Pectoris
A completed clinical trial evaluated the effects of inhaling diesel exhaust on exercise capacity in patients with stable angina due to coron…
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Reducing the Pro-ischaemic Effects of Air Pollution Exposure Using a Simple Face Mask [NA]
A completed clinical trial evaluating whether wearing a simple face mask reduces pro-ischemic effects of air pollution exposure in people wi…
-
CLINICAL_TRIALS trial_result · 2010-03-15Clinical Trial Update: Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3) [Phase 4]
Phase 4 trial ISAR-REACT-3 comparing unfractionated heparin with bivalirudin during percutaneous coronary intervention has completed, with r…
-
FDA approval · 2010-03-15FDA Approved: MATZIM LA — Original Application (Actavis Pharma, Inc.)
FDA approved MATZIM LA, a diltiazem hydrochloride extended-release tablet, under Actavis Pharma's original ANDA.
-
FDA approval · 2010-03-12FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited.
-
FDA approval · 2010-03-10FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for metoprolol tartrate.
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina [Phase 2]
Phase 2 trial assessing pharmacokinetics and tolerability of intravenous and oral CK-1827452 in patients with ischemic cardiomyopathy and an…
-
FDA approval · 2010-02-17FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for NORVASC (amlodipine besylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2010-01-19FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for metoprolol tartrate submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2010-01-19FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) submitted by Melinta Therapeutics, LLC.
-
FDA approval · 2010-01-13FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Cardene IV, a new intravenous formulation of nicardipine hydrochloride by Baxter Healthcare …
-
FDA approval · 2009-12-16FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Verapamil Hydrochloride filed by Wilshire Pharmaceuticals, Inc.
-
FDA approval · 2009-12-04FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approves a supplemental application for Cipla USA's amlodipine besylate, a generic product containing amlodipine besylate. The approval …
-
FDA approval · 2009-12-03FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for verapamil hydrochloride by Mylan Pharmaceuticals Inc., enabling the generic version to be market…
-
FDA approval · 2009-11-17FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Civica, Inc.)
FDA approved Civica, Inc.'s nicardipine hydrochloride as an original generic application (ANDA 090534), making a generic version of this cal…